A detailed history of Donald L. Hagan, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Donald L. Hagan, LLC holds 1,020 shares of LLY stock, worth $811,583. This represents 0.49% of its overall portfolio holdings.

Number of Shares
1,020
Previous 1,020 -0.0%
Holding current value
$811,583
Previous $923,000 2.17%
% of portfolio
0.49%
Previous 0.52%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 20, 2022

BUY
$224.85 - $279.04 $4,497 - $5,580
20 Added 2.0%
1,020 $282,000
Q2 2021

Jul 19, 2021

BUY
$180.55 - $233.54 $180,550 - $233,540
1,000 New
1,000 $230,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Donald L. Hagan, LLC Portfolio

Follow Donald L. Hagan, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Donald L. Hagan, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donald L. Hagan, LLC with notifications on news.